Amyris Inc

Specialty Chemicals
Basic Materials

Prices are adjusted according to historical splits.

Amyris Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$407.11 million
Book Value:
Revenue TTM:
$258.82 million
Operating Margin TTM:
Gross Profit TTM:
$93.49 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Amyris Inc had its IPO on 2010-09-28 under the ticker symbol AMRS.

The company operates in the Basic Materials sector and Specialty Chemicals industry. Amyris Inc has a staff strength of 980 employees.

Stock update

Shares of Amyris Inc opened at $0.12 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.1 - $0.2, and closed at $0.14.

This is a +100% increase from the previous day's closing price.

A total volume of 666,949,600 shares were traded at the close of the day’s session.

In the last one week, shares of Amyris Inc have slipped by -82.28%.

Amyris Inc's Key Ratios

Amyris Inc has a market cap of $407.11 million, indicating a price to book ratio of 3.0008 and a price to sales ratio of 2.0882.

In the last 12-months Amyris Inc’s revenue was $258.82 million with a gross profit of $93.49 million and an EBITDA of $-518654016. The EBITDA ratio measures Amyris Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Amyris Inc’s operating margin was -205.86% while its return on assets stood at -51.38% with a return of equity of -532.08%.

In Q3, Amyris Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 48.6%.

Amyris Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-1.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.03. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Amyris Inc’s profitability.

Amyris Inc stock is trading at a EV to sales ratio of 5.5866 and a EV to EBITDA ratio of -4.744. Its price to sales ratio in the trailing 12-months stood at 2.0882.

Amyris Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$754.06 million
Total Liabilities
$309.26 million
Operating Cash Flow
Capital Expenditure
$30.09 million
Dividend Payout Ratio

Amyris Inc ended 2023 with $754.06 million in total assets and $0 in total liabilities. Its intangible assets were valued at $754.06 million while shareholder equity stood at $-422583000.00.

Amyris Inc ended 2023 with $3.30 million in deferred long-term liabilities, $309.26 million in other current liabilities, 5032000.00 in common stock, $-2730381000.00 in retained earnings and $126.66 million in goodwill. Its cash balance stood at $18.49 million and cash and short-term investments were $18.49 million. The company’s total short-term debt was $89,949,000 while long-term debt stood at $673.93 million.

Amyris Inc’s total current assets stands at $272.48 million while long-term investments were $9.69 million and short-term investments were $0. Its net receivables were $91.55 million compared to accounts payable of $133.82 million and inventory worth $129.33 million.

In 2023, Amyris Inc's operating cash flow was $-30086000.00 while its capital expenditure stood at $30.09 million.

Comparatively, Amyris Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Amyris Inc stock is currently trading at $0.14 per share. It touched a 52-week high of $5.15 and a 52-week low of $5.15. Analysts tracking the stock have a 12-month average target price of $7.02.

Its 50-day moving average was $0.95 and 200-day moving average was $1.34 The short ratio stood at 9.33 indicating a short percent outstanding of 0%.

Around 2998.5% of the company’s stock are held by insiders while 3571.5% are held by institutions.

Frequently Asked Questions About Amyris Inc

The stock symbol (also called stock or share ticker) of Amyris Inc is AMRS

The IPO of Amyris Inc took place on 2010-09-28

Similar Industry Stocks (Specialty Chemicals)

Last Price
3M India Limited (3MINDIA)
Star Cement Limited (STARCEMENT)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.


5885 Hollis Street, EmeryVille, CA, United States, 94608